Celltrion Group provides biosimilar and innovative biopharmaceutical medications to help increase patient access to advanced therapies around the world. Celltrion Group offers biologics to about 110 countries, along with more than 30 global partners around the
Our client is a leading international biopharmaceutical company focused on developing and delivering innovative therapies for people living with rare and complex diseases. With a strong global presence and a patient-centric approach, the company is committed